PDLIM7 and nasopharyngeal carcinoma: Disruption of LMP1 in a third type of EBV-infected NPC cell line (NPC C666-1) by another CRISPR-Cas9 delivery method (i.e., poly[β-amino ester] or PBAE-plasmid polyplex nanoparticles [NPs]) also reduced tumor cell viability, cell growth, and the ability to form colonies [65].